Transitioning Select Chemotherapeutics to the Outpatient Setting Improves Care and Reduces Costs

Click to increase image sizeClick to decrease image size

Additional information

Notes on contributors

Ali Mcbride

Ali McBride, PharmD, MS, BCOP, is the former clinical coordinator, Hematology/Oncology; and Daniel Persky, MD, is associate director, Clinical Investigators, Therapeutic Development Program, University of Arizona Cancer Center, Tucson, Ariz.

Daniel Persky

Ali McBride, PharmD, MS, BCOP, is the former clinical coordinator, Hematology/Oncology; and Daniel Persky, MD, is associate director, Clinical Investigators, Therapeutic Development Program, University of Arizona Cancer Center, Tucson, Ariz.